Conference
Phase II study of neoadjuvant and adjuvant gefitinib (G) with neoadjuvant chemoradiotherapy (CRT) in operable esophageal adenocarcinoma (EAC).
Authors
Juergens RA; Gibson MK; Yang SC; Brock M; Heitmiller R; Tsottles N; Rudek MA; Canto M; Kleinberg L; Forastiere AA
Volume
28
Pagination
pp. e14532-e14532
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2010
DOI
10.1200/jco.2010.28.15_suppl.e14532
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X